Earnings Call · Q1 FY2021·2021-05-12

Q1 21EPS -10.34%·Rev n/aQ4 20EPS -12.50%·Rev n/aQ3 20EPS -10.34%·Rev n/aQ2 20EPS +2.10%·Rev n/a⚠ consensus missing

Marker Therapeutics, Inc. MRKR

Anthony Kim — Chief Financial Officer

Peter Hoang — Chief Executive Officer

Mythili Koneru — Medical or Clinical Lead

Juan Vera — Head of Manufacturing or CMC

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more MRKR calls or request research access.

More MRKR calls Browse calls Request research access